Claudia C. Pfleger
Aalborg, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts.
Journal: CNS drugs
Published: August 16, 2021
Benefit-risk Assessment of Cladribine Using Multi-criteria Decision Analysis (MCDA) for Patients With Relapsing-remitting Multiple Sclerosis.
Journal: Clinical therapeutics
Published: July 27, 2018
High treatment adherence, satisfaction, motivation, and health-related quality of life with fingolimod in patients with relapsing-remitting multiple sclerosis - results from a 24-month, multicenter, open-label Danish study.
Journal: Patient preference and adherence
Published: July 11, 2018
Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark.
Journal: Neurology
Published: April 17, 2018
Variations in multiple sclerosis practice within Europe - Is it time for a new treatment guideline?
Journal: Multiple sclerosis and related disorders
Published: January 20, 2016
Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study.
Minocycline added to subcutaneous interferon β-1a in multiple sclerosis: randomized RECYCLINE study.
Journal: European journal of neurology
Published: August 14, 2015
Physical and social environment and the risk of multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: January 15, 2014
Gender and autoimmune comorbidity in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 30, 2013
Reproduction and the risk of multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: March 20, 2013
Detection of caveolin-3/caveolin-1/P2X7R complexes in mice atrial cardiomyocytes in vivo and in vitro.
Journal: Histochemistry and cell biology
Published: April 09, 2012
Association between age, IL-10, IFNγ, stimulated C-peptide and disease progression in children with newly diagnosed Type 1 diabetes.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: December 14, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026